Kevin Kunzmann

Articles

Moderna COVID-19 Vaccine Shows Promise, Moves to Phase 3

July 16, 2020

The findings support the advancement of a 100-mcg dose vaccine to a phase 3 trial assessment in later summer 2020, while a phase 2 trial of a pair of different doses continues among 600 healthy adults.